GR3021952T3 - Triterpene derivatives and endothelin-receptor antagonists containing the same. - Google Patents
Triterpene derivatives and endothelin-receptor antagonists containing the same.Info
- Publication number
- GR3021952T3 GR3021952T3 GR960403369T GR960403369T GR3021952T3 GR 3021952 T3 GR3021952 T3 GR 3021952T3 GR 960403369 T GR960403369 T GR 960403369T GR 960403369 T GR960403369 T GR 960403369T GR 3021952 T3 GR3021952 T3 GR 3021952T3
- Authority
- GR
- Greece
- Prior art keywords
- endothelin
- same
- receptor antagonists
- triterpene derivatives
- hydrogen
- Prior art date
Links
- 150000003648 triterpenes Chemical class 0.000 title abstract 2
- 229940118365 Endothelin receptor antagonist Drugs 0.000 title 1
- 239000002308 endothelin receptor antagonist Substances 0.000 title 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004185 ester group Chemical group 0.000 abstract 2
- 230000002503 metabolic effect Effects 0.000 abstract 2
- 102000002045 Endothelin Human genes 0.000 abstract 1
- 108050009340 Endothelin Proteins 0.000 abstract 1
- 125000004450 alkenylene group Chemical group 0.000 abstract 1
- 125000002947 alkylene group Chemical group 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/18—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14041693 | 1993-06-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GR3021952T3 true GR3021952T3 (en) | 1997-03-31 |
Family
ID=15268217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GR960403369T GR3021952T3 (en) | 1993-06-11 | 1996-12-10 | Triterpene derivatives and endothelin-receptor antagonists containing the same. |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US5463107A (enExample) |
| EP (2) | EP0628569B1 (enExample) |
| JP (1) | JP2724114B2 (enExample) |
| KR (1) | KR100201015B1 (enExample) |
| CN (2) | CN1041938C (enExample) |
| AT (2) | ATE142640T1 (enExample) |
| DE (2) | DE69410081T2 (enExample) |
| DK (1) | DK0628569T3 (enExample) |
| ES (2) | ES2094622T3 (enExample) |
| GR (1) | GR3021952T3 (enExample) |
| TW (1) | TW272974B (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2094622T3 (es) | 1993-06-11 | 1997-01-16 | Shionogi & Co | Derivados triterpenos y antagonistas del receptor de endotelina que los contiene. |
| CA2218028C (en) * | 1995-06-02 | 2010-07-06 | Shionogi & Co., Ltd. | Brain edema inhibitor |
| WO1997027314A1 (fr) * | 1996-01-23 | 1997-07-31 | Shionogi & Co., Ltd. | Processus de production d'analogues d'acide oleanolique par la culture de racine pileuse |
| JP2007217438A (ja) * | 2001-07-17 | 2007-08-30 | Shionogi & Co Ltd | 注射用医薬製剤 |
| TWI232102B (en) * | 2001-07-17 | 2005-05-11 | Shionogi & Co | A pharmaceutical formulation for injection |
| CN1310940C (zh) * | 2002-03-22 | 2007-04-18 | 盐野义制药株式会社 | 三萜衍生物的制备方法 |
| WO2004108163A1 (ja) * | 2003-06-04 | 2004-12-16 | Shionogi & Co., Ltd. | 低帯電性粉末の製造方法 |
| TWI335335B (en) * | 2004-03-24 | 2011-01-01 | Shionogi & Co | A novel crystal of a triterpene derivative |
| JP4827189B2 (ja) | 2004-05-14 | 2011-11-30 | 塩野義製薬株式会社 | 過酸化水素およびタングステン触媒を用いたアルコールの酸化反応 |
| JPWO2006077801A1 (ja) * | 2005-01-18 | 2008-06-19 | 塩野義製薬株式会社 | ミリセロン誘導体の製造方法 |
| US20090030075A1 (en) * | 2005-12-21 | 2009-01-29 | Mitsuyoshi Ninomiya | Remedy for and Method of Treating Ischemic Cerebral Stroke |
| US20070207989A1 (en) * | 2006-03-03 | 2007-09-06 | Savipu Pharmaceuticals | Diterpene derivatives for the treatment of cardiovascular, cancer and inflammatory diseases |
| US7323476B2 (en) * | 2006-03-03 | 2008-01-29 | Savipu Pharmaceuticals | Myriceric acid derivatives for the treatment of cancer, cardiovascular and inflammatory diseases |
| WO2007103727A2 (en) * | 2006-03-03 | 2007-09-13 | Savipu Pharmaceuticals | Triterpene derivatives for the treatment of cancer and inflammatory disease by inhibition of nf-kb |
| US20070243273A1 (en) * | 2006-04-12 | 2007-10-18 | Savipu Pharmaceuticals | Reduction of the Deleterious Effects of Tobacco Smoking |
| US20080017207A1 (en) * | 2006-07-18 | 2008-01-24 | Savipu Pharmaceuticals | Reduction of the Deleterious Effects of Tobacco Smoking by the Induction of Phase 2 Enzymes by Nerf2 |
| US20080187608A1 (en) * | 2007-02-05 | 2008-08-07 | Savipu Pharmaceuticals | Enriched fractions from clary sage for the treatment of cancer, cardiovascular and inflammatory diseases |
| US20090022821A1 (en) * | 2007-07-17 | 2009-01-22 | Inderjit Kumar Dev | Compositions from wax myrtle for the treatment of cancer, cardiovascular and inflammatory diseases |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE164588T1 (de) | 1991-01-29 | 1998-04-15 | Shionogi & Co | Triterpenderivat |
| ES2094622T3 (es) | 1993-06-11 | 1997-01-16 | Shionogi & Co | Derivados triterpenos y antagonistas del receptor de endotelina que los contiene. |
-
1994
- 1994-06-09 ES ES94304165T patent/ES2094622T3/es not_active Expired - Lifetime
- 1994-06-09 ES ES95112524T patent/ES2116663T3/es not_active Expired - Lifetime
- 1994-06-09 DE DE69410081T patent/DE69410081T2/de not_active Expired - Lifetime
- 1994-06-09 EP EP94304165A patent/EP0628569B1/en not_active Expired - Lifetime
- 1994-06-09 TW TW083105247A patent/TW272974B/zh not_active IP Right Cessation
- 1994-06-09 AT AT94304165T patent/ATE142640T1/de not_active IP Right Cessation
- 1994-06-09 DK DK94304165.7T patent/DK0628569T3/da active
- 1994-06-09 EP EP95112524A patent/EP0682009B1/en not_active Expired - Lifetime
- 1994-06-09 AT AT95112524T patent/ATE165811T1/de not_active IP Right Cessation
- 1994-06-09 DE DE69400506T patent/DE69400506T2/de not_active Expired - Lifetime
- 1994-06-09 JP JP6127420A patent/JP2724114B2/ja not_active Expired - Fee Related
- 1994-06-10 US US08/258,392 patent/US5463107A/en not_active Expired - Lifetime
- 1994-06-10 CN CN94102805A patent/CN1041938C/zh not_active Expired - Fee Related
- 1994-06-10 KR KR1019940013068A patent/KR100201015B1/ko not_active Expired - Fee Related
-
1995
- 1995-07-26 US US08/507,211 patent/US5587505A/en not_active Expired - Lifetime
-
1996
- 1996-12-10 GR GR960403369T patent/GR3021952T3/el unknown
-
1998
- 1998-05-20 CN CN98109227A patent/CN1070183C/zh not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69400506T2 (de) | 1997-02-13 |
| DK0628569T3 (da) | 1996-09-30 |
| DE69400506D1 (de) | 1996-10-17 |
| EP0682009A2 (en) | 1995-11-15 |
| US5463107A (en) | 1995-10-31 |
| EP0628569B1 (en) | 1996-09-11 |
| CN1106368A (zh) | 1995-08-09 |
| EP0682009B1 (en) | 1998-05-06 |
| CN1215725A (zh) | 1999-05-05 |
| DE69410081T2 (de) | 1998-10-08 |
| ATE165811T1 (de) | 1998-05-15 |
| ES2094622T3 (es) | 1997-01-16 |
| CN1070183C (zh) | 2001-08-29 |
| KR950000663A (ko) | 1995-01-03 |
| KR100201015B1 (ko) | 1999-06-15 |
| EP0682009A3 (en) | 1997-02-05 |
| CN1041938C (zh) | 1999-02-03 |
| US5587505A (en) | 1996-12-24 |
| JP2724114B2 (ja) | 1998-03-09 |
| ATE142640T1 (de) | 1996-09-15 |
| EP0628569A1 (en) | 1994-12-14 |
| TW272974B (enExample) | 1996-03-21 |
| JPH0753484A (ja) | 1995-02-28 |
| ES2116663T3 (es) | 1998-07-16 |
| DE69410081D1 (de) | 1998-06-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GR3021952T3 (en) | Triterpene derivatives and endothelin-receptor antagonists containing the same. | |
| SI1920764T1 (sl) | Izopropilni estri fluprostenola za uporaba pri zdravljenju glavkoma in očesne hipertenzije | |
| LTIP1979A (en) | New sulphonylaminopyrimidines with therapic activity | |
| EP1473294A3 (en) | Substituted 1,3-oxathiolanes with antiviral properties | |
| GR3035526T3 (en) | Retroviral protease inhibitors. | |
| EP0896533A4 (en) | PENTAFLUOROBENZEN SULPHONAMIDES AND ANALOGS | |
| KR960014782B1 (en) | Benzisothiazolinone 1-dioxide derivatives and elastase inhibitors composition comprising them | |
| ES2087038A1 (es) | Nuevas piperidinas con actividad antagonista del paf. | |
| TW228521B (enExample) | ||
| IL98156A0 (en) | Pharmaceutical compositions containing magnesium-pyridoxal-5'-phosphate-glutaminate | |
| HU9501801D0 (en) | Lactame-compounds as pharmaceutical active component | |
| FR2658509B1 (enExample) | ||
| AU8383691A (en) | Amelinic compounds and use thereof in self-extinguishing polymeric compositions | |
| MY111439A (en) | Thymosin alpha 1 derivatives | |
| IL90559A0 (en) | Analgetic derivatives of phenothiazine | |
| HU9400908D0 (en) | Pharmaceutical compositions for treatng skin disorders | |
| ZA935017B (en) | Novel 4-(3-benzofuranyl) piperidinyl and 4-(3-benzothienyl) piperidinyl derivatives | |
| NZ334119A (en) | Use of pentynoic acid derivatives as neurotrophic and antiproliferative agents | |
| NO941084L (no) | Neuroleptiske 2-substituerte perhydro-1-H-pyrido[1,2-aÅpyraziner | |
| AU2101792A (en) | Methanoanthracene D2 dopamine antagonists | |
| ZA929529B (en) | Pharmaceutical composition for the improvement of dysuria. | |
| IL112110A0 (en) | Octahydro-1h-isoindoles and pharmaceutical compositions containing them | |
| ATE92461T1 (de) | Gegen die zerebrale insuffizienz wirksame verbindungen. | |
| ITMI911095A0 (it) | Composizioni farmaceutiche contenenti l'estere 4-(2 metilamminoetil)- 1,2- fenilenicodell`acido 2-metilpropanoico per il trattamento della neurootticopatia glaucomatosa | |
| ES472208A1 (es) | Procedimiento para la obtencion de nuevos derivados de 2- bencimidazol. |